About
Respiratory Motion, a Senzime Company, is a Boston-based medical technology firm focused on developing advanced systems for monitoring respiratory function and vital signs. Their flagship product, the ExSpiron System, is a non-invasive device that measures patients' breathing volume and real-time breathing frequency. It is the only system on the market with these capabilities and has received CE and FDA approval, validated on over 6,000 patients. The ExSpiron System is designed for continuous, real-time respiratory monitoring, which is essential in various clinical settings. This technology helps healthcare providers detect respiratory distress or failure early, enabling timely and informed decisions regarding patient care. Following its acquisition by Senzime in July 2022, Respiratory Motion enhances Senzime's portfolio with its innovative respiratory monitoring solutions, supporting critical care and patient safety in hospitals and clinical environments.
Keywords
Company Information
-
Employees 13
-
Founded 2010
-
Annual Revenue $6000000
-
Total Funding $5800000
Location
80 Coolidge Hill Rd, Watertown, Massachusetts, United States, 02472
